Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Ardigò

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Opinion in Clinical Nutrition and Metabolic Care|June 11, 2008
Dietary antioxidants and glucose metabolismLaura Franzini, Diego Ardigò, Ivana Zavaroni
Bioinformatics (Oxford, England)|August 12, 2008
Clinically driven semi-supervised class discovery in gene expression dataIsrael Steinfeld, Roy Navon, Diego Ardigò, et al.
Diabetes Technology & Therapeutics|July 16, 2013
A glucose model based on support vector regression for the prediction of hypoglycemic events under free-living conditionsEleni I Georga, Vasilios C Protopappas, Diego Ardigò, et al.
Stem Cells Translational Medicine|December 28, 2017
Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European UnionGraziella Pellegrini, Diego Ardigò, Giovanni Milazzo, et al.
Food & Function|August 8, 2012
Quercetin-3-O-glucuronide affects the gene expression profile of M1 and M2a human macrophages exhibiting anti-inflammatory effectsEleonora Derlindati, Margherita Dall'Asta, Diego Ardigò, et al.
Pharmaceutical Medicine|August 9, 2024
P.O.L.A.R. Star: A New Framework Developed and Applied by One Mid-Sized Pharmaceutical Company to Drive Digital Transformation in R&DRiccardo Mariani, Maria Carmela De Vuono, Elena Businaro, et al.
European Journal of Endocrinology|August 3, 2005
Relationship between leptin, insulin, body composition and liver steatosis in non-diabetic moderate drinkers with normal transaminase levelsSilvia Valtueña, Filippo Numeroso, Diego Ardigò, et al.
Expert Opinion on Drug Delivery|July 4, 2024
Challenges and opportunities in neurometabolic disease treatment with enzyme deliveryDavid Begley, Reinhard Gabathuler, Gregory Pastores, et al.
Atherosclerosis|August 7, 2009
The increase in plasma PAI-1 associated with insulin resistance may be mediated by the presence of hepatic steatosisDiego Ardigò, Laura Franzini, Silvia Valtueña, et al.
Advances in Experimental Medicine and Biology|March 25, 2011
Enabling heterogeneous data integration and biomedical event prediction through ICT: the test case of cancer reoccurrenceMarco Picone, Sebastian Steger, Konstantinos Exarchos, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Opinion in Clinical Nutrition and Metabolic Care|June 11, 2008
Dietary antioxidants and glucose metabolismLaura Franzini, Diego Ardigò, Ivana Zavaroni
Bioinformatics (Oxford, England)|August 12, 2008
Clinically driven semi-supervised class discovery in gene expression dataIsrael Steinfeld, Roy Navon, Diego Ardigò, et al.
Diabetes Technology & Therapeutics|July 16, 2013
A glucose model based on support vector regression for the prediction of hypoglycemic events under free-living conditionsEleni I Georga, Vasilios C Protopappas, Diego Ardigò, et al.
Stem Cells Translational Medicine|December 28, 2017
Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European UnionGraziella Pellegrini, Diego Ardigò, Giovanni Milazzo, et al.
Food & Function|August 8, 2012
Quercetin-3-O-glucuronide affects the gene expression profile of M1 and M2a human macrophages exhibiting anti-inflammatory effectsEleonora Derlindati, Margherita Dall'Asta, Diego Ardigò, et al.
Pharmaceutical Medicine|August 9, 2024
P.O.L.A.R. Star: A New Framework Developed and Applied by One Mid-Sized Pharmaceutical Company to Drive Digital Transformation in R&DRiccardo Mariani, Maria Carmela De Vuono, Elena Businaro, et al.
European Journal of Endocrinology|August 3, 2005
Relationship between leptin, insulin, body composition and liver steatosis in non-diabetic moderate drinkers with normal transaminase levelsSilvia Valtueña, Filippo Numeroso, Diego Ardigò, et al.
Expert Opinion on Drug Delivery|July 4, 2024
Challenges and opportunities in neurometabolic disease treatment with enzyme deliveryDavid Begley, Reinhard Gabathuler, Gregory Pastores, et al.
Atherosclerosis|August 7, 2009
The increase in plasma PAI-1 associated with insulin resistance may be mediated by the presence of hepatic steatosisDiego Ardigò, Laura Franzini, Silvia Valtueña, et al.
Advances in Experimental Medicine and Biology|March 25, 2011
Enabling heterogeneous data integration and biomedical event prediction through ICT: the test case of cancer reoccurrenceMarco Picone, Sebastian Steger, Konstantinos Exarchos, et al.
Pageof 3